Enhancers require an active resetting phase after transcriptional activation
Arif Hussain Najar, Rajat Mann, Subhashis Indra…·Dimple Notani
The paper identifies AR as the factor driving active enhancer resetting after transcriptional activation, which prevents transcriptional hyperactivation in ER-positive breast cancer.